The largest database of trusted experimental protocols

Dmed f12 medium

Manufactured by Thermo Fisher Scientific
Sourced in United States

DMED-F12 medium is a cell culture medium designed for the growth and maintenance of a variety of cell types. It is a combination of Dulbecco's Modified Eagle's Medium (DMEM) and Ham's F-12 Nutrient Mixture, providing a balanced formulation of essential nutrients, vitamins, and salts to support cellular growth and viability.

Automatically generated - may contain errors

5 protocols using dmed f12 medium

1

Isolation and Treatment of Primary Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary microglia were isolated from brains of neonatal C57BL/6 mice (P0–P3) as described.21 The purified microglial cells were cultured at 37°C in DMED–F12 medium (Gibco) containing 10% fetal bovine serum (Gibco). After 7 days, microglia were pre‐treated with 10, 50, or 100 μM ASD (Alfabiotech) or pioglitazone (10 μM, Sigma‐Aldrich).37 After 30 min, microglia were treated for 24 or 48 h with either 50 ng/mL LPS (Sigma‐Aldrich) or phosphate‐buffered saline (PBS; BOSTER). Experimental groups were as follows: control group (Ctrl), not treated with ASD or LPS; LPS group (LPS), treated with LPS but not ASD; LPS + ASD (10, 50, 100 μM) group, treated with LPS and ASD at the indicated concentrations; and LPS + pioglitazone group, treated with LPS and 10 μM pioglitazone. At each time point, microglia were collected and transferred to new plates for further experiments.
+ Open protocol
+ Expand
2

Breast Cancer Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines used in this study were obtained from the ATCC (American Type Culture Collection, Manassas, VA, USA) and were cultured at 37 °C with 5 % CO2. HCC1937 and HCC1806 cell lines were cultured in RPMI 1640 medium (Gibco, Carlsbad, CA, USA) supplemented with 10 % FBS (fetal bovine serum, Gibco). MDA-MB-468, MCF-7 and SKBR3 cell lines were maintained in DMEM medium (Gibco) with 10 % FBS. The MDA-MB-231 cell line was maintained in F12 (1:1) medium (Gibco) with 5 % FBS. T47D and BT474 cell lines were cultured in RPMI 1640 medium supplemented with 10 % FBS and 0.2 Units/ml insulin. MCF10A cell line was maintained in DMED F12 medium (Gibco) with 5 % horse serum (Gibco), 20 ng/ml epidermal growth factor (Peprotech, Rocky Hill, NJ, USA), 100 ng/ml cholera toxin (Sigma, St Louis, MO, USA), 0.16 Units/ml insulin and 500 ng/ml hydrocortisone (Sigma).
+ Open protocol
+ Expand
3

Silencing Tlr2 and Beclin1 in NPCs upon P. acnes infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with siRNAs-Tlr2, siRNA-Beclin1 or with control siRNA using Lipofectamine® 3000 (Lipo3000, Thermo Fisher Scientific, Inc., MA, USA) at 37 °C in a humidified incubator with 5% CO2. The siRNAs were designed and synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China). Another group of cells was transfected with a GFP-labeled nonspecific siRNA that served as the negative control (NC). The sequences of the siRNAs used in the present study were as follows: siRNA-Tlr2 sense: 5′-CAG AUC UAC AGA GCU AUG ATT-3′, anti-sense: 5′-UCA UAG CUC UGU AGA UCU GTT-3′; siRNA-Beclin1 sense: 5′-GUG GAA UGG AAU GAG AUU ATT-3′, anti-sense: 5′-UAA UCU CAU UCC AUU CCA CTT-3′; NC-siRNA sense: 5′-UUC UCC GAA CGU GUC ACG UTT-3′, anti-sense: 5′-ACG UGA CAC GUU CG GAG AAT T -3′. When NPCs seeded into 6-well plates reached 80% confluence, transfection was performed by mixing 5 µL siRNA with 5 µL Lipo3000 in a final volume of 2000 µL DMED/F12 medium (Gibco; Thermo Fisher Scientific, Inc.) containing 15% serum without antibiotics, according to the manufacturer’s protocol. After 16 h of transfection, the cells were infected with P. acnes for 8 h. Finally, the mRNA and protein were extracted from the cells. Transfections were performed in triplicate, and the experiment was repeated at least three times.
+ Open protocol
+ Expand
4

Microglia Isolation and Inflammation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary microglia were isolated from brains of neonatal C57BL/6 mice (P0–P3) as described [15 ]. The purified microglial cells were cultured at 37 °C in DMED-F12 medium (Gibco, CA, USA) containing 10% fetal bovine serum (Gibco, CA, USA). Seven days later, microglia were pre-treated with 40 μM ASA VI (Alfabiotech, Chengdu, China) or 10 μM GW9662 (Sigma-Aldrich, MO, USA) [24 (link)]. After 30 min, microglia were treated for 24 h with either 50 ng/mL lipopolysaccharide (LPS; Sigma-Aldrich, MO, USA) or phosphate-buffered saline (PBS; BOSTER, Wuhan, China) (control). Following the immunocytochemistry, RT-PCR analysis and western blot analysis were performed.
+ Open protocol
+ Expand
5

Culturing Breast Cancer Stem-like Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 human breast cancer cells (obtained from Chinese Academy of Medical Sciences, Beijing, China) were grown in DMEM medium (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) and 100 U/mL penicillin and 100 μg/mL streptomycin (all from Sigma, St Louis, MO, USA) at 37 °C in 5% CO2 incubator.
For the culture of cancer stem-like cells (CSLCs), MCF-7 cells (2000 cells/mL) were cultured in 6-well ultralow attachment plate (corning, USA) and suspended in serum-free DMED-F12 medium (Gibco, Carlsbad, CA, USA) supplemented with 1 × B27, 20 ng/mL epidermal growth factor (EGF), 20 ng/mL basic fibroblast growth factor (bFGF), 0.4% (w/v) bovine serum albumin, 100 U/mL penicillin and 100 μg/mL streptomycin (all from Sigma, St Louis, MO, USA). After 10 days, CSLCs were harvested and grew as nonadherent spherical clusters of cells, named mammospheres. For further experimental use, mammospheres were collected by gentle centrifugation (800× g, 5 min), dissociated into single cells and then cultured to generate mammospheres of the next generation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!